February 2, 2018—A team of independent health policy experts have questioned the major findings in a recent New England Journal of Medicine (NEJM) study critical of the 340B drug pricing program. In its Jan. 24 issue, the journal published a study authored by Sunita Desai, Ph.D., and J. Michael McWilliams, M.D., Ph.D., that raised questions about whether 340B hospitals are … [Read more...]
Appeals Court Expedites Lawsuit to Stop Deep Medicare Cuts to 340B Hospitals
January 31, 2018—A federal appeals court has agreed to fast-track its consideration of a lawsuit aimed at stopping a nearly 30 percent cut in 340B disproportionate share hospitals’ (DSH) and rural referral centers’ (RRC) Medicare Part B drug reimbursement that took effect on Jan. 1. … [Read more...]
Flaws in Understanding Intent of 340B Program Lead to Incomplete Conclusions in Study
January 25, 2018—A recent study published in the New England Journal of Medicine (NEJM)[i] suggests that hospital use of the 340B program is “contrary to the goals of the program,” relying on a finding that there is no evidence of hospitals using 340B savings to expand care or lower mortality among low-income patients. This finding is inconsistent with existing research that … [Read more...]
The 340B Commitment to Service
January 15, 2018—On today’s national holiday, people nationwide are participating in a national day of service in communities that need help the most. Every day for the past 25 years, hospitals and health systems participating in the 340B drug discount program have served the underserved in those same communities. Underserved patients – including those with low incomes, … [Read more...]
340B Hospitals Will Ask Appeals Court to Stop Harmful Medicare Part B Cuts
January 12, 2018—Three national hospital groups and three local health systems will appeal a federal district judge’s dismissal of their lawsuit aimed at stopping a nearly 30 percent cut in 340B disproportionate share hospitals’ (DSH) and rural referral centers’ (RRC) Medicare Part B drug reimbursement that took effect on Jan. 1. On Jan. 9, the groups and systems formally … [Read more...]
House Panel Issues 340B Report; 340B Health Both Appreciative and Concerned
January 10, 2018—The full House Energy & Commerce Committee released a report this afternoon calling on Congress to clarify the 340B program’s intent, give the Health Resources and Services Administration (HRSA) more regulatory authority over the program, increase reporting requirements for hospitals, and revise hospital eligibility requirements. 340B Health, which … [Read more...]
Drug Companies May Owe Medicaid $1.3 Billion in Unpaid Rebates
January 3, 2018—Pharmaceutical companies may have misclassified 885 drugs for Medicaid drug rebate purposes in 2016, with the top 10 in terms of highest total reimbursement accounting for potentially $1.3 billion in lost Medicaid drug rebates, the U.S. Department of Health and Human Services Office of Inspector General (OIG) reports. Four drug manufacturers were responsible for … [Read more...]